期刊
CELL DEATH & DISEASE
卷 13, 期 3, 页码 -出版社
SPRINGERNATURE
DOI: 10.1038/s41419-022-04656-5
关键词
-
类别
资金
- Ministry of Science and Technology of Taiwan [MOST 110-2320-B-039-022-MY3, MOST 110-2314-B-039-008, MOST 110-2314-B-039-012]
- China Medical University Beigang Hospital [110CMUBHR-07]
- China Medical University Hospital [DMR-111-078, DMR-111-117, DMR-111-108]
This study investigated the effects of melatonin on osteoarthritis and its underlying mechanisms. The results demonstrated that melatonin reversed the pathological changes and reduced the expression of inflammatory factors by targeting the MT1 melatonin receptor. Furthermore, the anti-osteoarthritic activities of melatonin were associated with the upregulation of microRNA-185a through the PI3K/Akt and ERK signaling pathways.
Progressive structural changes in osteoarthritis (OA) involve synovial inflammation and angiogenesis, as well as activation of the proinflammatory cytokines tumor necrosis factor alpha (TNF-alpha) and interleukin (IL)-8, and the angiogenic factor vascular endothelial growth factor (VEGF). The endogenous hormone melatonin (N-acetyl-5-methoxytryptamine) is involved in antioxidative and anti-inflammatory activities, but how it antagonizes OA progression via its specific receptors is unclear. Here, we demonstrate that the MT1 melatonin receptor, but not the MT2 receptor, is highly expressed in normal tissue and only minimally in OA tissue. By targeting the MT1 receptor, melatonin reversed OA-induced pathology and effectively reduced levels of TNF-alpha, IL-8, and VEGF expression in OA synovial fibroblasts and synovium from rats with severe OA. Interestingly, we found that the anabolic activities of melatonin involved the MT1 receptor, which upregulated microRNA-185a through the PI3K/Akt and ERK signaling pathways in OA synovial fibroblasts. Our investigation confirms the role of the MT1 receptor in melatonin-induced anti-catabolic effects in OA disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据